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Homologous recombination (HR) is a DNA double-strand break (DSB) repair pathway
that utilizes a homologous template to fully repair the damaged DNA. HR is critical to
maintain genome stability and to ensure genetic diversity during meiosis. A specialized
class of enzymes known as recombinases facilitate the exchange of genetic information
between sister chromatids or homologous chromosomes with the help of numerous
protein accessory factors. The majority of the HR machinery is highly conserved among
eukaryotes. In many protozoan parasites, HR is an essential DSB repair pathway
that allows these organisms to adapt to environmental conditions and evade host
immune systems through genetic recombination. Therefore, small molecule inhibitors,
capable of disrupting HR in protozoan parasites, represent potential therapeutic
options. A number of small molecule inhibitors were identified that disrupt the activities
of the human recombinase RAD51. Recent studies have examined the effect of
two of these molecules on the Entamoeba recombinases. Here, we discuss the
current understandings of HR in the protozoan parasites Trypanosoma, Leishmania,
Plasmodium, and Entamoeba, and we review the small molecule inhibitors known to
disrupt human RAD51 activity.
Keywords: homologous recombination, DNA repair, double-strand break repair, protozoan parasites,
recombination inhibitors, RAD51, DMC1

INTRODUCTION
DNA double-stranded breaks (DSBs) can occur due to exogenous or endogenous events.
Exogenous sources of DSBs include reactive oxygen species generated from exposure to ionizing
radiation and radiomimetic chemicals (Mehta and Haber, 2014), while endogenous sources of
DSBs include erroneous DNA replication that can lead to the collapse of replication forks.
Additionally, DSBs can be intentionally introduced into the genome through programmed events
such as in meiosis, where the production of crossover products is essential. Whether they are
produced intentionally or as a result of genotoxic events, unrepaired DSBs threaten the genome
stability of an organism. Defects in DSB repair pathways have been associated with sterility, cancer,
and chromosomal rearrangements (San Filippo et al., 2008; Moynahan and Jasin, 2010; Hunter,
2015).
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conducts a homology search to identify a homologous sequence
that will serve as a template for repair. Rad51 preferentially
utilizes the sister chromatid as a template in order to prevent
loss of heterozygosity, whereas Dmc1 prefers the homologous
chromosome with the goal of generating crossover products.
In either case, the presynaptic filament invades the duplex
DNA and facilitates the base-pairing of the 30 ssDNA with
its complementary sequence. As a result, the homologous
strand of the duplex DNA is displaced to form a displacement
loop (D-loop) structure. The 30 end of the invading strand
primes DNA synthesis by a polymerase to replace DNA that
was lost at the DSB site. As a result of strand invasion and
DNA synthesis to repair the damaged DNA, two distinct DNA
joint molecules can be formed. These DNA intermediates
(the initial D-loop or Holliday junctions, which are associated
with meiosis and form after D-loop extension, second end
capture, ligation, and a second synthesis event) are resolved by
one of two major pathways to ultimately yield non-crossover
products or crossover products (Matos and West, 2014; Morrical,
2015).
The complex process of DSB repair by HR requires numerous
accessory proteins to proceed with accuracy and efficiency
(Table 1). RPA (replication protein A) is a heterotrimeric
complex composed of three subunits (RPA1, RPA2, RPA3) that
coat the ssDNA overhangs to protect them from nucleases and
to prevent the formation of secondary structure (Binz et al.,
2004). Although the DNA binding activity of RPA is necessary
for HR, this function also represents a barrier to the recombinase
loading. Various recombination mediators help to overcome this
inhibition by displacing RPA and loading the recombinase onto
the ssDNA, including Saccharomyces cerevisiae Rad52 (radiationsensitive 52) and human BRCA2 (breast cancer susceptibility
gene 2) (Sung, 1997; Jensen et al., 2010; Liu et al., 2010; Thorslund
et al., 2010). Recently, DSS1 (deleted in split hand/split foot
syndrome) was shown to aid BRCA2 in loading RAD51 onto
RPA-coated ssDNA (Yang et al., 2002; Zhao et al., 2015). DSS1
functions as a DNA mimic that competes with authentic DNA
to displace RPA, allowing BRCA2 to load RAD51 onto ssDNA
(Zhao et al., 2014). Another factor, Hop2-Mnd1 (homologouspairing protein 2—meiotic nuclear division protein 1), is a
meiosis-specific heterodimeric protein complex that promotes
recombinase-meditated D-loop formation by stabilizing the
presynaptic filament and bringing the duplex DNA into close
proximity with the presynaptic filament for more efficient
homologous DNA pairing (Chi et al., 2007; Pezza et al., 2007).
Other accessory proteins, such as RAD54 (radiation-sensitive
54), promote the search for homology by the recombinase and
help to dissociate the recombinase from the DNA after strand
exchange has occurred (Petukhova et al., 1998; Mason et al.,
2015). The high degree of conservation of the HR pathway across
divergent eukaryotic species emphasizes its indispensable nature.
The clinical relevance of HR in non-communicable human
disease, such as cancer, makes it a potential therapeutic target.
Furthermore, since HR plays a role in virulence of eukaryotic
pathogens (see below), the components of this DNA repair
system may also serve as a target for the development of new
drugs to fight infectious disease.

Four major pathways function in DSB repair: nonhomologous end joining (NHEJ), single-strand annealing
(SSA), alternative end joining (ALT-EJ), and homologous
recombination (HR) (Figure 1). NHEJ (also known as classicalNHEJ or canonical-NHEJ) is the major DSB repair pathway,
and is mediated by many factors, which include Ku70, Ku80,
XRCC4, and DNA ligase IV (Lieber, 2010). In this pathway,
the ends of the DSB are protected to prevent nucleolytic end
resection (Mimori and Hardin, 1986; Paillard and Strauss,
1991), followed by ligation to mend the DSB (Figure 1A).
NHEJ is active during the entire cell cycle, and is the pathway
responsible for V(D)J recombination in antibody variation
(Soulas-Sprauel et al., 2007; Malu et al., 2012). NHEJ can result
in full restoration of the DSB. However, if there is any enzymatic
processing or degradation at the ends of the DSB, there will
be a loss of genetic information once repaired (Betermier
et al., 2014); thus, NHEJ is often associated with chromosomal
alterations at the break site (Ghezraoui et al., 2014). Repair by
SSA is initiated when a DSB occurs at a locus with extensive
homology in the sequences flanking the break site (Figure 1B).
Once homology is located (≥100 base pairs), the sequences
are annealed by the DNA annealing factor RAD52 (Morales
et al., 2015) and the non-homologous overlapping ends are
endonucleolytically processed followed by DNA polymerase
gap filling and ligation to restore the break (Bhargava et al.,
2016). Similarly, ALT-EJ (also known as a microhomology
mediated-EJ) DSB repair occurs through the recognition and
annealing of short sequences called microhomology (≤10 base
pairs) within the sequences flanking the DSB (Wang and Xu,
2017) (Figure 1C). The two main protein factors involved in
mediating ALT-EJ are poly-ADP-ribose polymerase (PARP)
and DNA polymerase theta (POLQ) (Bhargava et al., 2016).
SSA and ALT-EJ are both active early in the S and G2 phases
of the cell cycle. Both pathways result in the loss of DNA
sequence between the annealed substrates (SSA results in large
deletion events and ALT-EJ results in small deletions). As a
result, both SSA and ALT-EJ are considered to be mutagenic
DSB repair pathways (Bhargava et al., 2016). In contrast,
HR relies on a homologous template to restore the damaged
DNA in its entirety (Figure 1D). HR is active during the S
and G2 phases of the cell cycle due to the presence of sister
chromatids or homologous chromosomes (in meiosis) to act
as the template. The HR pathway requires enzymatic resection
of the ends of the DSB to produce 30 single-stranded DNA
(ssDNA) overhangs. These overhangs serve as the nucleation
site for a recombinase, the central enzyme of HR. There are two
conserved recombinases among eukaryotes, Rad51 (radiationsensitive 51) and Dmc1 (disrupted meiotic cDNA 1) (Moore,
1978; Bishop et al., 1992). Rad51 is the lead recombinase
during mitosis, and Dmc1 serves as the major recombinase
during meiosis, in which Rad51 plays a supportive role (Bishop,
2012). These different processes result in the requirement for
different accessory proteins to modulate the functions of each
recombinase. Nonetheless, the mechanisms of action for both
recombinases are similar. The active ATP-bound form of the
recombinase forms a right-handed presynaptic, nucleoprotein
filament on the ssDNA overhang. The presynaptic filament then
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FIGURE 1 | Double-strand Break Repair Pathways. (A) The non-homologous end-joining (NHEJ) pathway is facilitated when the ends of the DSB are protected from
resection and then ligated to mend the DSB. (B) Single-strand annealing (SSA) is a DSB repair pathway that anneals long stretches of homologous sequences
flanking the DSB site. (C) The alternative end-joining (ALT-EJ) pathway anneals microhomologous sequences next to the DSB site. (D) In the homologous
recombination (HR) repair pathway, a recombinase (Rad51 and/or Dmc1 in most eukaryotes) utilizes a homologous template (i.e., sister chromatid) to faithfully repair
the DSB.
TABLE 1 | HR DSB repair proteins, species, functions, and UniProtKB identifiers of human, yeast, and putative protozoan parasite homologs.
Function

DSB End Resection

Single-strand DNA
Binding
Recombinase
(Meiosis-specific)
Accessory Proteins

Homo sapiens

Saccharomyces
cerevisiae

Entamoeba
histolytica

Trypanosoma
brucei

Plasmodium
falciparum

Leishmania
major

MRE11

Mre11

C4LVX7

Q8T8P1–?

A0A1C3KMQ6

E9ADG7

RAD50

Rad50

N9V1K1

Q384J8

C6KSQ6

Q4Q8L7

NSB1

Xrs2

?

?

?

?

RPA1-RPA2RPA3

Rfa1-Rfa2-Rfa3

?-?-?

?-?-?

A0A1C3KN47/
A0A1C3KQ72

?-?-?

RAD51

Rad51

Q86C17∗

Q384K0∗

Q8IIS8

O61127

DMC1

Dmc1

C4LTR6∗

Q38E34∗

A0A1C3KPB3

O61128

RAD54

Rad54

C4LVM6∗

Q385M5

Q8IAN4

Q4QH75

RAD54B

Rdh54

N9TAM9

?

?

?

RAD55

Rad55

?

?

?

?

RAD57

Rad57

?

?

?

?

–

RAD59

?

?

?

?

HOP2

Hop2

?

?

?

?

MND1

Mnd1

M3TLC0

?

C6S3J7

Q4QAN2

Single-Strand
Annealing

RAD52

Rad52

C4M197

?

?

?

Mediator

BRCA2

Rad52

N9TLS7

Q4GZF5

?

Q4QD38

∗ Indicates

characterized enzymes parasites.
?Indicates no known homolog.

are conserved among protozoan parasites (Table 1); however,
the mechanisms of HR in many of these pathogens are largely
unknown. Over the past few years, our understanding of
HR in these organisms has increased from studies involving
Trypanosoma, Leishmania, Plasmodium, and Entamoeba.
Homologous recombination plays a significant role in the
survival of T. brucei, the protozoan parasite responsible for
African trypanosomiasis (sleeping sickness). T. brucei generates

HOMOLOGOUS RECOMBINATION IN
PROTOZOAN PARASITES
Homologous recombination is essential in many protozoan
parasites. These parasites utilize HR to adapt to diverse
environmental conditions, evade host immune systems, and
respond to DSBs (Deitsch et al., 1997; Bhattacharyya et al.,
2004). Many of the core eukaryotic enzymes involved in HR
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FIGURE 2 | Trypanosoma brucei Homologous Recombination VSG Switching. VSG Switching by homologous recombination in T. brucei occurs through gene
conversion. This can occur by exchanging a VSG gene into a transcriptionally active site or through multiple VSG gene segment conversions into the transcriptionally
active site.

dmc1−/− , respectively) in T. brucei were not sensitive to DNA
damage, failed to impact VSG switching frequency, and had
unaltered recombination efficiency, suggesting that TbDmc1
played no role in these processes (Proudfoot and McCulloch,
2006). These results were in direct contrast to the studies
of T. brucei rad51−/− mutants (McCulloch and Barry, 1999;
Conway et al., 2002b). Currently, there is no evidence to suggest
that TbRad51 compensates for the loss of TbDmc1, or vice
versa. Future work will be necessary to reveal the biochemical
underpinnings of Rad51 and Dmc1 recombinases from T. brucei
and T. cruzi.
Leishmaniasis is a diverse disease characterized by three
main forms: fever/anemia/weight loss, skin lesions, or mucous
membrane destruction. Leishmaniasis is caused by the protozoan
parasite Leishmania. Leishmania utilize HR to induce gene
rearrangement events in response to oxidative stress, while HRmediated DNA amplification events serve as a mechanism for
drug resistance (Beverley, 1991; Ouellette and Papadopoulou,
1993; Nathan and Shiloh, 2000; Ubeda et al., 2008, 2014; MonteNeto et al., 2015). Although HR is exploited in vitro to create
null mutants of L. major for study (Cruz et al., 1991), the
mechanisms of HR in L. major are largely unknown. There are
a few studies demonstrating the existence of functional Rad51
in Leishmania. Namely, in vivo studies of L. major showed
that the typically low levels of Rad51 (LmRad51) expression
increased in response to the DNA damaging agent phleomycin
(McKean et al., 2001). Similarly, L. infantum Rad51 (LiRAD51)
was highly expressed in response to phleomycin exposure, while
the expression levels of the L. infantum ortholog of BRCA2
(LiBRCA2) were unchanged, similar to what has been reported
in human cells (Lu et al., 2005). LiRAD51 and LiBRCA2 both
localize to punctate foci in the nucleus; however, LiRAD51 fails
to localize to the nucleus in LiBRCA2-deficient cells (Genois
et al., 2012). Biochemically, LmRad51 ATP hydrolysis activity
was stimulated by the presence of both ssDNA and dsDNA
(McKean et al., 2001). Another biochemical study showed
that LiRAD51 binds DNA—with an apparent higher affinity
for ssDNA over dsDNA (Genois et al., 2012), and LiRAD51
can facilitate homologous DNA pairing (Genois et al., 2012).

antigenic variation through DNA recombination to evade the
host immune system (McCulloch and Barry, 1999). In T. brucei,
antigenic variation consists of repeatedly changing the expression
of the Variant Surface Glycoprotein (VSG) genes that encode
an outer protective coat of the parasite (Cross, 1975). T. brucei
expresses more than 1000 VSG genes and pseudogenes one
at a time (Borst, 2002; Marcello and Barry, 2007; McCulloch
et al., 2015). One of the ways in which T. brucei can switch the
expression of the VSG gene is through gene conversion of entire
VSG genes or partial VSG pseudogenes into a transcriptionally
active site using HR (Figure 2) (Borst, 2002; Marcello and
Barry, 2007; Vink et al., 2012). It was shown that Rad51 was
a major factor in this process, as null mutations of Rad51 in
T. brucei (TbRad51) led to a reduction in the VSG switching
frequency (McCulloch and Barry, 1999). Moreover, mutations
in genes involved in other DSB repair pathways (i.e., NHEJ)
induced no change in VSG switching frequency (Conway et al.,
2002a), indicating that VSG switching is likely dependent on
TbRad51. However, the frequency of VSG switching was reduced
rather than eliminated in TbRad51 mutants, suggesting that
RAD51-mediated HR is not the only pathway for VSG switching
(McCulloch and Barry, 1999; Conway et al., 2002a,b). Indeed,
ALT-EJ also exists as an alternative pathway to HR in this
pathogen (Conway et al., 2002b; Barnes and McCulloch, 2007;
Glover et al., 2008, 2011). Furthermore, TbRad51 was reported
to be important in response to DNA damage. When DSBs were
induced in T. brucei, TbRad51 was shown to localize to subnuclear foci (Glover and Horn, 2012), and HR served as the
predominant DSB repair pathway (Barnes and McCulloch, 2007;
Glover et al., 2008).
Trypanosoma cruzi is a protozoan parasite that causes Chagas
disease, or American trypanosomiasis. T. cruzi Rad51 (TcRad51)
has a significant role in the response to and repair of DNA
damage caused by ionizing radiation, as shown by in vivo
analyses (Regis-da-Silva et al., 2006). Interestingly, the genomes
of T. brucei and T. cruzi contain Dmc1 genes with 65% and
70% identity to human DMC1, respectively (Proudfoot and
McCulloch, 2006; Kelso et al., 2017). However, heterozygous
and homozygous knockout DMC1 mutants (DMC1+/− and

Frontiers in Microbiology | www.frontiersin.org

4

September 2017 | Volume 8 | Article 1716

Kelso et al.

HR in Protozoan Parasites and Recombinase Inhibitors

Furthermore, LiBRCA2 was reported to load LiRAD51 onto
RPA coated ssDNA (Genois et al., 2012), similar to its human
homolog (Jensen et al., 2010; Liu et al., 2010; Thorslund et al.,
2010).
P. falciparum causes malaria in humans. The genome of
P. falciparum contains many of the HR proteins (Table 1)
(Gardner et al., 2002; Kirkman et al., 2014). In vivo studies
using an exogenous HR reporter substrate with an inducible
DSB site found that HR was the preferred DSB repair pathway
when a homologous template was available, and during the
more common haploid state, ALT-EJ was preferred (Kirkman
et al., 2014). Upon exposure to the DNA damaging agent, methyl
methanesulfonate (MMS), P. falciparum Rad51 (Pf Rad51)
expression increased (Bhattacharyya and Kumar, 2003).
Biochemical analysis of Pf Rad51 showed that it hydrolyzed ATP
and facilitated efficient DNA strand exchange (Bhattacharyya
et al., 2005). Pf Rad51 required ATP binding but not hydrolysis
to catalyze DNA strand exchange in vitro (Bhattacharyya et al.,
2005), similar to human RAD51. In support of this notion,
mutational analysis of the ATP binding motif of Pf Rad51
showed that Pf Rad51K143R significantly impacted the in vivo
function of Pf Rad51 (Roy et al., 2014). Furthermore, P. berghei
(responsible for malaria in rodents) and S. cerevisiae expressing
the Pf Rad51-K143R variant were found to be hypersensitive to
MMS treatment (Roy et al., 2014).
In addition to the studies on Pf Rad51, homologs of other
HR proteins were shown to have similar functions and/or
responses to DNA DSBs in Plasmodium as reported for their
human counterparts. For example, Rad54 is a Rad51 stimulating
protein, and Pf Rad54 similarly stimulated the homologous DNA
pairing activity of Pf Rad51 (Gopalakrishnan and Kumar, 2013).
BLM (Bloom syndrome protein) is a DNA helicase involved
in DSB end-resection, and Pf Blm possessed helicase activity
(Rahman et al., 2016). The protein complex Mre11 (meiotic
recombination 11), Rad50 (radiation-sensitive 50), and NBS1
(involved in Nijmegen breakage syndrome) recognizes and endresects DNA DSBs, and Pf Mre11 demonstrated nuclease activity
and interacted with Pf Rad50 (Badugu et al., 2015). Lastly, diploid
zygotes of Plasmodium undergo meiosis in the insect vector to
produce haploid cells, a state in which Dmc1 becomes relevant.
One study in P. berghei null for dmc1 demonstrated that PbDmc1
was essential for proper oocyst development (Mlambo et al.,
2012). PbDmc1 null cells were also shown to be highly sensitive
to a DNA damaging agent (Mlambo et al., 2012).
Entamoeba histolytica is the parasite responsible for amoebic
dysentery and amoebic liver abscess. The life cycle of E. histolytica
consists of a tetra-nucleated cyst that is transmitted through
water or food sources by fecal contamination (Figure 3).
When ingested by the host, the mature, tetra-nucleated cyst
can undergo excystation in the small intestine resulting in
the release of eight trophozoites that can colonize the large
intestine. Trophozoites multiply by binary fission and produce
multinucleated cysts through the process of encystation (Dobell,
1928; Cleveland and Sanders, 1930; Ratcliffe and Geiman, 1934;
Koushik et al., 2014). There is ample support for HR in
E. histolytica. For example, the genome of E. histolytica contains
the majority of the HR core genes (Table 1) (Bhattacharya
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et al., 2000). Also, genome duplication events, unscheduled
gene amplification events, and genetic rearrangements are
reported in E. histolytica and thought to be mediated by HR
(Orozco et al., 1988; Baez-Camargo et al., 1996; Bhattacharya
et al., 2000; Mukherjee et al., 2008). The first study on
HR in E. histolytica monitored the response of E. histolytica
to UV-C radiation, which is known to cause DNA damage
(Lopez-Casamichana et al., 2008). Many hallmarks of HR were
observed upon DNA damage induction in E. histolytica: the
histone H2AX was phosphorylated (indicating DNA damage),
cell survivability was not affected (indicating DSB repair
occurred), the core HR genes were differentially expressed
in response to irradiation, EhRad51 expression (mRNA and
protein) peaked rapidly in response to DNA damage, and
EhRad51 formed nuclear foci in response to DNA damage
(Lopez-Casamichana et al., 2008; Charcas-Lopez Mdel et al.,
2014). During growth stresses (heat shock, oxygen stress, serum
starvation) and in response to DNA damage (UV irradiation),
inverted repeat sequences located either on a plasmid or in
the E. histolytica genome underwent recombination (Singh
et al., 2013). This represents the first direct evidence for
HR in E. histolytica. Biochemically, Lopez-Casamichana et al.
(2008) showed that partially purified EhRad51 bound DNA and
facilitated homologous DNA pairing (Lopez-Casamichana et al.,
2008). The findings were recently extended by a report that
demonstrated EhRad51 was not only capable of binding DNA
and forming D-loops, but that EhRad51 hydrolyzed ATP, formed
presynaptic filaments, and catalyzed DNA strand exchange
over thousands of base pairs (Kelso et al., 2016). Although
E. histolytica reproduce asexually through binary fission, the
occurrence of meiosis in E. histolytica was first proposed to
occur during encystation based on increased expression of
meiosis-specific genes (Ehrenkaufer et al., 2013). Additional
support for this notion came from monitoring the expression
of meiosis-specific genes in the reptilian amoebozoa parasite,
E. invadens during encystation (Singh et al., 2013). More
recently, biochemical analysis of EhDmc1 demonstrated the
enzyme hydrolyzed ATP in the presence of DNA, bound DNA,
formed nucleoprotein filaments, and catalyzed homologous DNA
pairing and DNA strand exchange (Kelso et al., 2015). Taken
together, the evidence suggests that mitotic and meiotic HR
occur and are likely important for encystation in Entamoeba
(Figure 3).
Currently, the roles of other DSB repair pathways in protozoan
parasites are largely uncharacterized. As mentioned above, ALTEJ has been reported for some parasites, but the mechanisms
remain elusive (Conway et al., 2002b; Barnes and McCulloch,
2007; Glover et al., 2008, 2011; Kirkman et al., 2014). As for
SSA, although many genomes of protozoan parasites contain the
RAD52 gene, T. brucei is the only pathogen to demonstrate a
potential for SSA (Glover and Horn, 2009). Lastly, the genomes
of some parasites, like T. brucei and E. histolytica, contain
factors necessary for NHEJ (e.g., Ku); however, many of the key
components of this pathway are missing such as DNA ligase IV
and XRCC4 homologs (Burton et al., 2007). In fact, T. brucei Ku
was shown to have a role in telomere length maintenance, but
DSB repair occurred independent of Ku (Conway et al., 2002a).
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FIGURE 3 | Life Cycle of Entamoeba histolytica. The human host ingests the mature cyst. The cyst moves to the small intestine where excystation occurs, resulting
in the release of multiple trophozoites that migrate to the large intestine. Trophozoites either invade the mucous membrane of the host or encyst and exit the host for
future infections.

TARGETING HOMOLOGOUS
RECOMBINATION WITH SMALL
MOLECULE INHIBITORS

the targeting of enzymes involved in HR in protozoan parasites,
which rely on HR for diverse environmental adaptations, host
immune evasion, and drug resistances (Deitsch et al., 1997;
Bhattacharyya et al., 2004).
RAD51 serves as a reasonable drug target for protozoan
parasites because it is important for the repair of damaged
DNA by HR. However, for RAD51 to be an effective target for
small molecule inhibitors in these pathogens, it is essential to
develop inhibitors that are species-specific, since RAD51 is also
ubiquitously expressed in the human host. Currently, there is
limited structural information about the recombinases, which
hinders the potential for structure-based drug design. Due to
the availability of purified recombinases, high throughput screens
could provide a powerful platform for identifying potential

Studies of small molecule inhibitors targeting the proteins
involved in HR have increased in recent years (Bryant et al.,
2005; Ishida et al., 2009; Huang et al., 2011, 2012; Takaku
et al., 2011; Budke et al., 2012, 2013; Huang and Mazin, 2014;
Normand et al., 2014). Many current anticancer therapies, such
as irradiation and chemotherapy, are designed to induce DNA
damage and provoke an apoptotic response. By targeting major
HR enzymes like RAD51, RAD54, and BRCA2, the susceptibility
of cancer cells could increase when combined with other DNAdamaging therapies. An analogous argument could be made for
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FIGURE 4 | Inhibitors of human RAD51. RAD51 inhibitors can prevent RAD51 from self-associating or from binding ssDNA and/or dsDNA. DIDS and B02 disrupt
ssDNA and dsDNA binding. Chicago Sky Blue prevents filament formation but it is unknown if this is through inhibition of ssDNA binding or RAD51 polymerization.
RI-1 and RI-2 block RAD51 polymerization binding sites, and the BRC peptide binds filament-dissociated RAD51 monomers, leading to inhibition. Halenaquinone
disrupts the dsDNA binding of RAD51.

the interstrand crosslinking agents cisplatin and mitomycin-C
and to PARP1 inhibitors, which target the PARP1 system
responsible for repair of ssDNA breaks (Huang et al., 2011,
2012; Huang and Mazin, 2014). When tested with EhDmc1
and EhRad51, B02 failed to disrupt their DNA strand exchange
activity at concentrations that inhibited human RAD51 (Kelso
et al., 2016). This was the first study to demonstrate species
selectivity by small molecule inhibitors of human and protozoan
recombinases. Importantly, these findings provide evidence
that inhibitors could potentially be tailored to target specific
recombinases.
There are additional small molecule inhibitors reported to
disrupt human RAD51 activities that have not been characterized
for their efficacy against protozoan recombinases. Halenaquinone
disrupts the ability of RAD51 to bind dsDNA regardless of
the presence of ssDNA (Takaku et al., 2011). This suggests
that the compound binds to the dsDNA binding site, severely
compromising the ability of RAD51 to catalyze homologous
DNA pairing (Figure 4). Thus, in vivo studies demonstrated
that halenaquinone suppressed the formation and retention
of RAD51 foci at DSB sites (Takaku et al., 2011). Although
halenaquinone interacts with RAD51 in a manner similar to
DIDS, it does not exhibit the same level of toxicity for human
cells (Takaku et al., 2011).
RI-1 is a compound that was shown to inhibit human
RAD51 presynaptic filament formation by irreversibly binding to
cysteine-319 at the oligomerization interface (Figure 4) (Budke
et al., 2012). By inhibiting monomer-monomer interaction, RI-1
prevents polymerization of the RAD51 filament onto ssDNA
and consequently inhibits the assembly of RAD51 foci in vivo
(Budke et al., 2012). Additionally, RI-1 was shown to sensitize
cancer cells to mitomycin-C, a compound that induces DNA

compounds that demonstrate efficient inhibition of parasitic
recombinases but not human recombinases. Additionally, there
are many well-characterized biochemical assays that could
act as secondary analyses to aid in the understanding of
mechanisms of inhibition. On a related note, recent studies
have utilized small molecules, previously demonstrated to inhibit
human RAD51, to target the activities of the E. histolytica
recombinases (Kelso et al., 2015, 2016). The small molecule 4,40 diisothiocyanostilbene-2,20 -disulfonic acid (DIDS) was found
to directly interact with human RAD51 and interfere with
its ability to bind ssDNA and dsDNA (Figure 4) (Ishida
et al., 2009). By interfering with the ability of RAD51 to bind
DNA, DIDS decreases the presynaptic filament formation of
RAD51, which is essential for DNA strand exchange, D-loop
formation, and ATP hydrolysis (Ishida et al., 2009). This
small molecule was also shown to disrupt the recombinase
activities of both EhDmc1 and EhRad51 in vitro (Kelso
et al., 2015, 2016). Notably, encystation was significantly
hindered in E. invadens when DIDS was present (Kelso
et al., 2016). Despite its efficacy in these pathogens, DIDS
exhibits high toxicity for human cells, complicating its use
as a potential anti-pathogen treatment (Ishida et al., 2009).
Interestingly, in the same study by Kelso et al. (2016), another
human RAD51 small molecule inhibitor, B02, was tested. B02
was reported to disrupt RAD51 binding to ssDNA during
presynaptic filament formation. In addition, B02 disrupts the
subsequent binding of dsDNA to the RAD51-ssDNA complex
(Figure 4) (Huang et al., 2011). As a result, B02 inhibits
human RAD51-mediated DNA strand exchange and D-loop
formation activities (Huang et al., 2011). In vivo studies
revealed that B02 also prevents RAD51 foci formation at DSBs
and effectively sensitizes human cells to DNA damage by
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necessary to examine this hypothesis. Many of the RAD51
inhibitors reviewed here (DIDS, Halenaquinone, B02, CBS, BRC
peptide) impede the interaction between RAD51 and DNA. As
this function is essential for RAD51 filament formation and
localization to DSB sites, it is an effective target to achieve
inhibition of RAD51 activity in HR. Another class of RAD51
inhibitors (including RI-1 and RI-2) disrupt presynaptic filament
formation by physically preventing RAD51 polymerization
onto ssDNA. Again, inhibition of RAD51 at this early HR
stage abolishes repair of DSBs, and therefore can lead to cell
death. The ability to disrupt RAD51 in parasites and not
inhibit human RAD51 will be critical for the development of
new species-specific small molecule inhibitors. Analysis of the
targeted impact of some of these molecules on EhRad51 versus
human RAD51 suggests that there is some degree of variance
between the homologs that allows molecule specificity (note the
specificity of B02 for human RAD51). Since protozoan parasites
rely on HR for host immune evasion and drug resistance,
targeting the major enzymes involved in the HR pathway
could lead to new therapeutic intervention strategies. For
example, under stressful environmental conditions, E. histolytica
can undergo encystation for survival, which involves multiple
rounds of DNA replication that produces a polyploid cyst.
It has been suggested that HR plays a substantial role in
encystation in E. histolytica, which has been modeled in the
related reptilian parasite, E. invadens. Thus, inhibition of
Entamoeba HR via EhRad51 small molecule inhibitors could
limit Entamoeba pathogenicity by obstructing the encystation
pathways. Future studies are necessary to determine the efficacy
of these human recombinase inhibitors on the survivability
of protozoan parasites. Additionally, small molecule inhibitor
studies on human RAD51 could provide a platform for future
compound design against the RAD51 recombinase from other
organisms.

damage via cross-linking. RI-1 reacts with thiol groups (hence
conjugation to cysteine-319) and therefore has the potential for
off-target effects. Thus, RI-2, a derivative of RI-1, was developed
to inhibit RAD51 via the same mechanism but in a reversible
capacity in order to reduce the likelihood of serious off-target
binding effects (Figure 4) (Budke et al., 2013). RI-2 was also
shown to have a longer half-life than RI-1 and is a functional
inhibitor of RAD51 in human cells. However, due to the nature
of its reversible binding to the cysteine-319 of RAD51, RI-2
requires higher concentrations to achieve the same efficacy as the
irreversibly bound RI-1 (Budke et al., 2013).
Chicago Sky Blue (CSB) is a potent inhibitor of human RAD51
activity, with sufficient inhibition observed in the 400 nM range
(Normand et al., 2014). CSB inhibits D-loop formation and
DNA strand exchange activity of RAD51 by preventing filament
assembly of RAD51 onto ssDNA, effectively inhibiting its HR
activities (Normand et al., 2014). However, it is unclear if the
suppression of RAD51-ssDNA binding occurs by interfering with
the ability of RAD51 to bind ssDNA (as seen with DIDS) or by
disruption of protein polymerization onto ssDNA via binding
at the protein–protein interface (as seen with RI-1 and RI-2)
(Figure 4). Importantly, CSB exhibits the lowest IC50 (400 nM)
of the RAD51 inhibitory compounds, making it a potent RAD51
inhibitor with significant clinical potential (Normand et al.,
2014).
Lastly, a short peptide of the BRC4 repeat from human BRCA2
was shown to dissociate the RAD51 filament by binding to
the filament-dissociated monomers of RAD51 thereby rendering
RAD51 inactive through sequestration (Figure 4) (Nomme et al.,
2008).
Given that RAD51 is highly conserved among eukaryotes
and is ubiquitously expressed, other HR proteins might serve
as alternative therapeutic targets. Currently, HR in protozoan
parasites is an emerging field, and therefore, the enzymes
involved are not well understood. As this field develops, new HR
targets that are essential and specific to parasites may emerge.
Consequently, identifying if these exist in protozoan parasites
would be valuable for potential pathogenic targets.
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